跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUPIVACAINE INJECTION BP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BUPIVACAINE INJECTION BP
Authorized
STANDARD
BUPIVACAINE INJECTION BP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b74bc41cc9667f8b
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
b74bc41cc9667f8b
Drug Approval Canada Name
BUPIVACAINE INJECTION BP
Product Name
BUPIVACAINE INJECTION BP
Status
Marketed
Status Date
2016-05-20
Original Market Date
2016-05-20
Din
02443686
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Block/Infiltration , Epidural
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB01 BUPIVACAINE
Atc Name
n 01 bb 01
Aig Number
0108896001
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
BUPIVACAINE HYDROCHLORIDE
2.5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b74bc41cc9667f8b
Type
Standard
Back to Health Canada Approvals